AVDL
Avadel Pharmaceuticals
AVDL
AVDL
83 hedge funds and large institutions have $259M invested in Avadel Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 81 → 83 (+2)
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
10% less capital invested
Capital invested by funds: $287M → $259M (-$27.5M)
Holders
83
Holding in Top 10
2
Calls
$6.67M
Puts
$3.66M
Top Buyers
| 1 | +$9.76M | |
| 2 | +$4.33M | |
| 3 | +$3.13M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$1.55M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.29M |
Top Sellers
| 1 | -$5.23M | |
| 2 | -$4.89M | |
| 3 | -$2.13M | |
| 4 |
JP Morgan Chase
New York
|
-$1.78M |
| 5 |
TLP
Tri Locum Partners
New York
|
-$1.45M |